Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants

NCT06566092 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Soft Tissue Sarcoma
Primary Central Nervous System Carcinoma
Melanoma
Rhabdomyosarcoma
Ewing Sarcoma

Interventions

BIOLOGICAL: LN-145/LN-144

Sponsor

Iovance Biotherapeutics, Inc.